Quantifying the Treatment Effect of Kidney Transplantation Relative to Dialysis on Survival Time: New Results Based on Propensity Score Weighting and Longitudinal Observational Data from Sweden.

Sweden average treatment effect dialysis inverse-probability-weighted regression adjustment approach kidney transplantation survival time

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
07 10 2020
Historique:
received: 01 09 2020
revised: 01 10 2020
accepted: 04 10 2020
entrez: 10 10 2020
pubmed: 11 10 2020
medline: 15 12 2020
Statut: epublish

Résumé

Using observational data to assess the treatment effects on outcomes of kidney transplantation relative to dialysis for patients on renal replacement therapy is challenging due to the non-random selection into treatment. This study applied the propensity score weighting approach in order to address the treatment selection bias of kidney transplantation on survival time compared with dialysis for patients on the waitlist. We included 2676 adult waitlisted patients who started renal replacement therapy in Sweden between 1 January 1995, and 31 December 2012. Weibull and logistic regression models were used for the outcome and treatment models, respectively. The potential outcome mean and the average treatment effect were estimated using an inverse-probability-weighted regression adjustment approach. The estimated survival times from start of renal replacement therapy were 23.1 years (95% confidence interval (CI): 21.2-25.0) and 9.3 years (95% CI: 7.8-10.8) for kidney transplantation and dialysis, respectively. The survival advantage of kidney transplantation compared with dialysis was estimated to 13.8 years (95% CI: 11.4-16.2). There was no significant difference in the survival advantage of transplantation between men and women. Controlling for possible immortality bias reduced the survival advantage to 9.1-9.9 years. Our results suggest that kidney transplantation substantially increases survival time compared with dialysis in Sweden and that this consequence of treatment is equally distributed over sex.

Identifiants

pubmed: 33036407
pii: ijerph17197318
doi: 10.3390/ijerph17197318
pmc: PMC7578980
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Transplantation. 2000 Mar 15;69(5):794-9
pubmed: 10755528
J Clin Epidemiol. 2006 May;59(5):437-47
pubmed: 16632131
Stat Med. 2014 Mar 30;33(7):1242-58
pubmed: 24122911
J Am Soc Nephrol. 2002 Sep;13(9):2353-62
pubmed: 12191980
PLoS One. 2016 Apr 15;11(4):e0153431
pubmed: 27082113
Emerg Themes Epidemiol. 2010 May 11;7(1):1
pubmed: 20459823
Med Decis Making. 2009 Nov-Dec;29(6):661-77
pubmed: 19684288
Int J Health Care Finance Econ. 2007 Dec;7(4):269-81
pubmed: 17657602
Nephrol Dial Transplant. 2010 May;25(5):1680-7
pubmed: 20038521
J Am Soc Nephrol. 2014 Sep;25(9):2113-20
pubmed: 24854268
Nephrol Dial Transplant. 2000 May;15(5):701-4
pubmed: 10809814
Epidemiology. 2010 Jan;21(1):13-5
pubmed: 20010207
J Clin Epidemiol. 2001 Apr;54(4):387-98
pubmed: 11297888
Am J Epidemiol. 2006 Feb 1;163(3):262-70
pubmed: 16371515
J Am Soc Nephrol. 2010 Mar;21(3):499-506
pubmed: 20133483
J Am Geriatr Soc. 2016 Oct;64(10):2003-2010
pubmed: 27612017
J Natl Cancer Inst. 2010 Dec 1;102(23):1780-93
pubmed: 20944078
Transplantation. 2014 Sep 27;98(6):653-9
pubmed: 24879382
Transplant Direct. 2018 Feb 02;4(2):e346
pubmed: 29464207
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Med Care. 2007 Oct;45(10 Supl 2):S103-7
pubmed: 17909367
BMJ. 2005 Apr 23;330(7497):960-2
pubmed: 15845982
N Engl J Med. 1999 Dec 2;341(23):1725-30
pubmed: 10580071
Transpl Int. 2018 Feb;31(2):125-130
pubmed: 29024071
Nephrol Dial Transplant. 2010 Jan;25(1):292-300
pubmed: 19749147

Auteurs

Ye Zhang (Y)

School of Sociology and Population Studies, Renmin University of China, Beijing 100872, China.
Health Economics Unit, Department of Clinical Sciences, Malmö, Lund University, 22381 Lund, Sweden.

Ulf-G Gerdtham (UG)

Health Economics Unit, Department of Clinical Sciences, Malmö, Lund University, 22381 Lund, Sweden.
Department of Economics, Lund University, 22363 Lund, Sweden.
Centre for Economic Demography, Lund University, 22363 Lund, Sweden.

Helena Rydell (H)

Department of Clinical Sciences Intervention and Technology, Karolinska Institute, 17177 Huddinge, Sweden.
Swedish Renal Registry, Department of Internal Medicine, Ryhov County Hospital, 55185 Jönköping, Sweden.

Johan Jarl (J)

Health Economics Unit, Department of Clinical Sciences, Malmö, Lund University, 22381 Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH